Effect of Empagliflozin on Inflammation

Clinical trial NCT07292909 · RECRUITING

Trial details

NCT number: NCT07292909
Sponsor: Hotel Dieu de France Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

CAD - Coronary Artery Disease Inflamation PCI SGLT 2 Inhibitors

Start date: 2025-09-01
Primary completion: 2027-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.